Status:

COMPLETED

Normal Tissue Oxygenation Following Radiotherapy

Lead Sponsor:

Essentia Health

Conditions:

Radiation Toxicity

Eligibility:

FEMALE

18+ years

Brief Summary

This study involves women who have had a diagnosis of breast cancer, and have had a lumpectomy with radiation treatments completed in the past year. The study will determine the level of oxygen in th...

Detailed Description

Successful completion of this study will provide data on changes in oxygenation in irradiated tissues. If changes are documented, this study would provide evidence supporting current models of tissue ...

Eligibility Criteria

Inclusion

  • Diagnosis of breast malignancy
  • Completion of breast irradiation one year (+/- 8 weeks) prior.
  • Surgical treatment with lumpectomy

Exclusion

  • Inability to tolerate the 20 minute transcutaneous oxygenation measurements
  • Allergy to adhesives
  • Bilateral disease or absence of control breast or previous radiotherapy to "control" breast
  • More than one course of radiotherapy to the breast

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00677040

Start Date

April 1 2008

End Date

August 1 2009

Last Update

November 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Essentia Health

Duluth, Minnesota, United States, 55805